Medpace Holdings Inc (MEDP)
Working capital turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 1,899,742 | 1,816,339 | 1,717,384 | 1,607,723 | 1,488,796 | 1,387,029 | 1,289,052 | 1,216,138 | 1,145,156 | 1,094,017 | 1,028,823 | 955,525 | 926,439 | 896,133 | 881,998 | 891,107 | 860,969 | 823,198 | 786,213 | 742,253 |
Total current assets | US$ in thousands | 593,828 | 448,881 | 378,927 | 367,622 | 333,962 | 337,741 | 328,887 | 355,969 | 690,912 | 641,220 | 550,100 | 533,380 | 473,651 | 395,005 | 319,082 | 303,002 | 317,028 | 250,397 | 194,344 | 182,375 |
Total current liabilities | US$ in thousands | 925,131 | 848,518 | 852,437 | 881,889 | 803,470 | 820,868 | 878,959 | 579,428 | 557,217 | 517,182 | 472,607 | 447,306 | 440,110 | 358,396 | 337,984 | 338,651 | 343,002 | 314,392 | 296,073 | 264,541 |
Working capital turnover | — | — | — | — | — | — | — | — | 8.57 | 8.82 | 13.28 | 11.10 | 27.62 | 24.48 | — | — | — | — | — | — |
December 31, 2023 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $1,899,742K ÷ ($593,828K – $925,131K)
= —
I'm sorry, but without specific values for working capital turnover provided in the table, I am unable to calculate or analyze the working capital turnover for Medpace Holdings Inc. Kindly provide the necessary figures for me to offer you a detailed and comprehensive analysis of the company's working capital turnover.
Peer comparison
Dec 31, 2023
Company name
Symbol
Working capital turnover
Medpace Holdings Inc
MEDP
—
Arrowhead Pharmaceuticals Inc
ARWR
0.95
Charles River Laboratories
CRL
7.40
Exelixis Inc
EXEL
1.98
Incyte Corporation
INCY
1.08
IQVIA Holdings Inc
IQV
—